GDS core Research Team. (2021) Global drug survey annual report. Executive summary. London: Global Drug Survey.
Preview | Title | Contact |
---|---|---|
|
PDF (Global drug survey annual report. Executive summary)
958kB |
Data collection period
GDS2020 ran between Nov 7th– Dec 30th, 2019 (before the COVID pandemic)
Sample characteristics Global Drug Survey 2020 (GDS2020)
Data from over 110,000 people from > 25 countries were used in the preparation of this report.
66% were male, 52% were aged under 25 years with 22% of the sample aged 35 years or older. 87% of the sample was white. 38% had at least an undergraduate degree as their highest level of educational attainment. 54% reported going clubbing 4 or more times per year.
Drug use: global sample
Of the 20 drugs used most commonly in the last 12 months:
→ 8 were psychedelic/dissociative drugs
→ 6 were stimulant drugs
→ 3 were prescription CNS depressants (opioids / benzodiazepines)
→ 2 were tobacco/nicotine-based products
→ 1 was alcohol
A Substance use and dependence > Prevalence > Problem substance use
B Substances > Cannabis / Marijuana
B Substances > Cannabis product (Cannabinoids)
B Substances > CNS stimulants > MDMA / Ecstasy
B Substances > Cocaine
B Substances > Opioids (opiates) > Opioid product
E Concepts in biomedical areas > Medical substance > Prescription drug (medicine / medication)
VA Geographic area > International
Repository Staff Only: item control page